Novel Protective Role for Gut Microbiota-derived Metabolite PAGln in Doxorubicin-induced Cardiotoxicity
Cardiovascular Drugs and Therapy · 2026
DOI: 10.1007/s10557-024-07665-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Drugs and Therapy, 2026. Verfasst von Jie Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China. Hauptthemen laut MEDLINE: Doxorubicin, Gastrointestinal Microbiome, Myocytes, Cardiac. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: the National Natural Scientific Foundation of China, Hunan Provincial Innovation Foundation for Postgraduate, Fundamental Research Funds for the Central Universities of Central South University.
Abstract (Originalsprache)
PURPOSE: Doxorubicin (Dox) is a classic anthracycline chemotherapy drug with cause cumulative and dose-dependent cardiotoxicity. This study aimed to investigate the potential role and molecular mechanism of phenylacetylglutamine (PAGln), a novel gut microbiota metabolite, in Dox-induced cardiotoxicity (DIC). METHODS: DIC models were established in vivo and in vitro, and a series of experiments were performed to verify the cardioprotective effect of PAGln. RNA sequencing (RNA-seq) was employed to explore the mechanism of PAGln in DIC. Subsequently, the differentially expressed genes (DEGs) were subjected to comprehensive analysis using diverse public databases, and RT-PCR was used to confirm the expression levels of the candidate genes. Finally, molecular docking techniques were used for validation. RESULTS: PAGln effectively prevented both in vivo and in vitro Dox-induced myocardial injury and cell apoptosis. RNA-seq results showed that 40 genes were up-regulated and 54 down-regulated in the Dox group compared to the Con group, displaying opposite changes in the Dox + PAGln group. Enrichment analysis highlighted several mechanisms by which PAGln alleviated Dox-induced cardiotoxicity, including the lipid metabolic process, calcium-mediated signaling, positive regulation of store-operated calcium channel activity, and hypertrophic cardiomyopathy. In vitro and in vivo experiments confirmed that PAGln treatment could reverse the changes in the expression levels of Klb, Ece2, Nmnat2, Casq1, Pak1, and Apob in Dox. Molecular docking results showed that these genes had good binding activity with PAGln. CONCLUSIONS: PAGln shows potential in alleviating Dox-induced cardiotoxicity, with Ece2 identified as key regulatory molecules related to endothelial dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
- Hunan Provincial Key Laboratory of Clinical Epidemiology, Xiangya School of Public Health, Central South University, Changsha, 410013, Hunan, China.
- Institute of Clinical Pharmacy, Central South University, Changsha, 410011, Hunan, China.
- Department of Ophthalmology, the First People's Hospital of Lanzhou City, Lanzhou, 730050, Gansu, China.
- School of Pharmacy, Hunan University of Chinese Medicine, Changsha, 410208, Hunan, China.
- Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China. liwq1204@csu.edu.cn.
ORCID-Profile: Wenqun Li
Förderung
- the National Natural Scientific Foundation of China
- Hunan Provincial Innovation Foundation for Postgraduate
- Fundamental Research Funds for the Central Universities of Central South University
- Hunan Provincial Natural Scientific Foundation
- Scientific Research Project of Hunan Provincial Health and Family Planning Commission
- Research Project established by Chinese Pharmaceutical Association Hospital Pharmacy department
Zitieren
APA
Huang, J., Hou, X., Zhou, N., Su, N., Wei, S., Yang, Y., Sun, T., Li, G., Li, W., & Zhang, B. (2026). Novel Protective Role for Gut Microbiota-derived Metabolite PAGln in Doxorubicin-induced Cardiotoxicity. Cardiovascular Drugs and Therapy. https://doi.org/10.1007/s10557-024-07665-y
Vancouver
Huang J, Hou X, Zhou N, Su N, Wei S, Yang Y, et al. Novel Protective Role for Gut Microbiota-derived Metabolite PAGln in Doxorubicin-induced Cardiotoxicity. Cardiovascular Drugs and Therapy. 2026. doi:10.1007/s10557-024-07665-y
BibTeX
@article{Huang2026,
author = {Huang, Jie and Hou, Xingyuan and Zhou, Ni and Su, Nan and Wei, Shanshan and Yang, Yuanying and Sun, Taoli and Li, Guangdi and Li, Wenqun and Zhang, Bikui},
title = {Novel Protective Role for Gut Microbiota-derived Metabolite PAGln in Doxorubicin-induced Cardiotoxicity},
journal = {Cardiovascular Drugs and Therapy},
year = {2026},
doi = {10.1007/s10557-024-07665-y}
}
EUVIMED